Prosecution Insights
Last updated: July 17, 2026

Fisherbroyles, LLP - Codexis, Inc.

7 pending office actions • 1 client • 7 examiners • 3 art units • 0 of 7 (0%) have an AI response strategy ready • 13 patents granted in the last 365 days

Quality Metrics (n=56260 apps, methodology: how we score firms)

82.6%
Allowance Rate
n=56260
+0.52σ
Allowance Rate (norm)
n=56260
3.4
OAs to Allowance
n=31880
-0.15σ
OAs to Allow (norm)
n=31880
1035 days
Time to Allowance
n=31880
+13.1pp
Interview Lift
n=56260
28.3%
RCE Rate
n=56260
1.3%
Appeal Rate
n=56260

Rejection Performance (% of received rejections ultimately overcome)

78.0%
§101 Overcome
n=1103
81.2%
§102 Overcome
n=4340
77.0%
§103 Overcome
n=19464
86.6%
§112 Overcome
n=3813

Specialization & Scale

G06F, A61K, H04L
Top CPC Subclasses
16%
Top-3 CPC Share
n=56260
25
Practitioners
n=56260
2250.4
Apps / Practitioner
n=56260

Portfolio Summary

7
Total Pending OAs
5
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 60 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (14%)
3
Easy (43%)
3
Unknown (43%)

Rejection Statute Mix

BucketCases
§103 only1 (14%)
§112 only2 (29%)
Double-patenting only1 (14%)
No statute on record3 (43%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
86% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
14% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

70 h
Manual time on pending OAs
14 h
Time saved (low, 20%)
24 h
Time saved (mid, 35%)
0.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HOLLAND, PAUL J 1 57.4% +64.6%
ROBINSON, HOPE A 1 67.8% +43.4%
MCKNIGHT, CIARA A 1 59.2% +38.1%
NOAKES, SUZANNE MARIE 1 73.1% +18.3%
FRONDA, CHRISTIAN L 1 82.6% +14.0%
STEADMAN, DAVID J 1 57.6% +29.6%
LU, FRANK WEI MIN 1 62.8% +67.2%

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18046893 RECOMBINANT REVERSE TRANSCRIPTASE VARIANTS LU, FRANK WEI MIN 51d overdue
18247054 ENGINEERED PANTOTHENATE KINASE VARIANT ENZYMES FRONDA, CHRISTIAN L 4d overdue
18516054 P450-BM3 VARIANTS WITH IMPROVED ACTIVITY MCKNIGHT, CIARA A 34d
18181760 ENGINEERED MONOAMINE OXIDASES FOR THE PREPARATION OF STEREOMERICALLY PURE FUSED BICYCLIC PROLINE COMPOUNDS STEADMAN, DAVID J 72d
18822990 ENGINEERED PANTOTHENATE KINASE VARIANT ENZYMES HOLLAND, PAUL J
18638060 ENGINEERED IMINE REDUCTASES AND METHODS FOR THE REDUCTIVE AMINATION OF KETONE AND AMINE COMPOUNDS ROBINSON, HOPE A
18485925 ENGINEERED 3-O-KINASE VARIANTS AND METHODS OF USE NOAKES, SUZANNE MARIE

Client Portfolio (1 client)

Client (Assignee)Pending OAs
Codexis 7

Top Art Units

Art UnitApps
16563
16522
16831

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18822990 ENGINEERED PANTOTHENATE KINASE VARIANT ENZYMES Codexis, Inc. HOLLAND, PAUL J DP Non-Final OA Pending Sep 03, 2024
18638060 ENGINEERED IMINE REDUCTASES AND METHODS FOR THE REDUCTIVE AMINATION OF KETONE AND AMINE COMPOUNDS Codexis, Inc. ROBINSON, HOPE A 1652 §112 Non-Final OA Pending Apr 17, 2024
18516054 P450-BM3 VARIANTS WITH IMPROVED ACTIVITY Codexis, Inc. MCKNIGHT, CIARA A 1656 Other Non-Final OA 34d Pending Nov 21, 2023
18485925 ENGINEERED 3-O-KINASE VARIANTS AND METHODS OF USE Codexis, Inc. NOAKES, SUZANNE MARIE 1656 Other Non-Final OA Pending Oct 12, 2023
18247054 ENGINEERED PANTOTHENATE KINASE VARIANT ENZYMES Codexis, Inc. FRONDA, CHRISTIAN L 1652 Other Final Rejection 4d overdue Pending Mar 28, 2023
18181760 ENGINEERED MONOAMINE OXIDASES FOR THE PREPARATION OF STEREOMERICALLY PURE FUSED BICYCLIC PROLINE COMPOUNDS Codexis, Inc. STEADMAN, DAVID J 1656 §103 Non-Final OA 72d Pending Mar 10, 2023
18046893 RECOMBINANT REVERSE TRANSCRIPTASE VARIANTS Codexis, Inc. LU, FRANK WEI MIN 1683 §112 Final Rejection 51d overdue Pending Oct 14, 2022

Managing Fisherbroyles, LLP - Codexis, Inc.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month